Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

NCT00375752 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Letrozole
DRUG: Zolendronic Acid

Sponsor

Novartis Pharmaceuticals